These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29196252)

  • 41. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
    Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J
    J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of atypical meningioma.
    Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
    J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy.
    Tanzler E; Morris CG; Kirwan JM; Amdur RJ; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):508-13. PubMed ID: 20452142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
    Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
    World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
    Wu A; Jin MC; Meola A; Wong HN; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
    Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW
    J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary management of atypical meningioma: treatment patterns and survival outcomes by patient age.
    Barthélemy E; Loewenstern J; Konuthula N; Pain M; Hall J; Govindaraj S; Bederson J; Shrivastava RK
    J Cancer Res Clin Oncol; 2018 May; 144(5):969-978. PubMed ID: 29500705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
    Weber DC; Ares C; Villa S; Peerdeman SM; Renard L; Baumert BG; Lucas A; Veninga T; Pica A; Jefferies S; Ricardi U; Miralbell R; Stelmes JJ; Liu Y; Collette L; Collette S
    Radiother Oncol; 2018 Aug; 128(2):260-265. PubMed ID: 29960684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management Approaches in WHO Grade III Meningioma: A National Oncology Trainees' Collaborative for Healthcare Research (NOTCH) UK Multi-Centre Retrospective Study.
    Dobeson CB; Baxter M; Rowe M; Kingdon S; Park S; Bond H; Taylor K; Islim AI; King J; Millward CP; Zakaria R; Clynch AL; Keshwara SM; Eltinay A; Kviat L; Robinson R; Haris PA; Samuel R; Venkatesh V; Derby S; Ahmad S; Smith F; Robinson S; Kathirgamakarthigeyan S; Narramneni LR; Hannan CJ; Lewis J;
    Clin Oncol (R Coll Radiol); 2024 Sep; 36(9):e301-e311. PubMed ID: 38849235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
    Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
    Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
    J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
    Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local control and overall survival in atypical meningioma: a retrospective study.
    Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of adjuvant radiotherapy in atypical meningioma.
    Park HJ; Kang HC; Kim IH; Park SH; Kim DG; Park CK; Paek SH; Jung HW
    J Neurooncol; 2013 Nov; 115(2):241-7. PubMed ID: 23949108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
    Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
    Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis.
    Chun SW; Kim KM; Kim MS; Kang H; Dho YS; Seo Y; Kim JW; Kim YH; Park CK
    Radiat Oncol; 2021 Feb; 16(1):34. PubMed ID: 33596974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
    Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
    Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
    Delgado-López PD; Corrales-García EM
    Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.